0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

SCLEROSING SARCOMA OF BONE

DEAN LEWIS, M.D.; CHARLES F. GESCHICKTER, M.D.
Arch Surg. 1937;34(6):1010-1031. doi:10.1001/archsurg.1937.01190120036003.
Text Size: A A A
Published online

In the older literature, both pathologic and surgical, sarcomas of bone were usually divided into the central and the periosteal type. The central type was frequently referred to as telangiectatic because of its hemorrhagic appearance on macroscopic examination and the absence of any clearly defined picture on microscopic examination. Tumors which are now referred to as osteolytic sarcoma, small round cell sarcoma of bone (Ewing's tumor) and central chondrosarcoma were also considered to be of this type. According to the older classification, periosteal sarcoma likewise had no well defined histologic characteristics. The fibrocellular forms, now recognized as either fascial sarcoma, or sarcoma arising from the nerve sheath and secondarily involving bone, and chondrosarcoma, which in the early stage is mostly subperiosteal and outside of the cortical bone, were classified under the periosteal type. Sclerosing sarcoma, which develops from the periosteum and cortical bone, usually at the ends of the long

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();